Benevolent AI (XAMS:BAI) EV-to-EBIT : -0.34 (As of Jun. 06, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Benevolent AI EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Benevolent AI's Enterprise Value is €28.47 Mil. Benevolent AI's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €-84.15 Mil. Therefore, Benevolent AI's EV-to-EBIT for today is -0.34.

The historical rank and industry rank for Benevolent AI's EV-to-EBIT or its related term are showing as below:

XAMS:BAI' s EV-to-EBIT Range Over the Past 10 Years
Min: -9.91 Med: -0.67 Max: 0.19
Current: -0.34

During the past 6 years, the highest EV-to-EBIT of Benevolent AI was 0.19. The lowest was -9.91. And the median was -0.67.

XAMS:BAI's EV-to-EBIT is ranked worse than
100% of 424 companies
in the Biotechnology industry
Industry Median: 9.96 vs XAMS:BAI: -0.34

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Benevolent AI's Enterprise Value for the quarter that ended in Dec. 2023 was €97.57 Mil. Benevolent AI's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €-84.15 Mil. Benevolent AI's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -86.25%.

Benevolent AI EV-to-EBIT Historical Data

The historical data trend for Benevolent AI's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Benevolent AI EV-to-EBIT Chart

Benevolent AI Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

-1.58

-1.16

Benevolent AI Semi-Annual Data
	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial				-	-	-1.58	-	-1.16

Competitive Comparison of Benevolent AI's EV-to-EBIT

For the Biotechnology subindustry, Benevolent AI's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Benevolent AI's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Benevolent AI's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Benevolent AI's EV-to-EBIT falls into.

Benevolent AI EV-to-EBIT Calculation

Benevolent AI's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	28.468	/	-84.153
	=	-0.34

Benevolent AI's current Enterprise Value is €28.47 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Benevolent AI's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €-84.15 Mil.

Benevolent AI (XAMS:BAI) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Benevolent AI's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	-84.153	/	97.5652
	=	-86.25 %

Benevolent AI's Enterprise Value for the quarter that ended in Dec. 2023 was €97.57 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Benevolent AI's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €-84.15 Mil.

Benevolent AI EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Benevolent AI's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Benevolent AI (XAMS:BAI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Benevolent AI (XAMS:BAI) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

BAIVF:USA 2XA:Germany

Address

4-8 Maple Street, London, GBR, W1T 5HD

Website

https://www.benevolent.com

Benevolent AI is a clinical-stage AI-enabled drug discovery company. It delivers novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform powers a growing in-house pipeline of over 20 drug programmes, spanning from target discovery to clinical studies, and it maintains commercial collaborations with pharmaceutical companies.

Benevolent AI (XAMS:BAI) Headlines

No Headlines